Medical diligence uncovers fallopian tube cancer after abnormal Pap test

BMJ case reports, 12(7), e229762

DOI 10.1136/bcr-2019-229762 PMID 31345832 Source

The fallopian tube has received attention as an origin of high-grade pelvic malignancies. This is a case of bilateral fallopian tube cancer discovered after an abnormal Pap test. A 62-year-old woman with a history of one term delivery had atypical glandular cells on a Pap test. She had an unsatisfactory colposcopy and a normal transvaginal ultrasound. A loop electrode excision procedure and hysteroscopy with dilation and curettage revealed atypical glandular cells concentrated in floating balls. CA-125 was 10 U/mL. A robotic hysterectomy revealed histopathological stage IIIA serous carcinoma arising from both fallopian tubes. She received six cycles of carboplatin and paclitaxel. After chemotherapy, she has no evidence of disease at 5 years. Fallopian tube carcinoma is a differential diagnosis of abnormal glandular cells on a Pap test. Diagnosis by systematic pursuit of abnormal tests can lead to successful treatment of a small disease burden.

fallopian tube cancer diagnosis, atypical glandular cells pap test, serous carcinoma fallopian tube, abnormal pap test workup, tubal cancer stage iiia, fallopian tube malignancy presentation, carboplatin paclitaxel tubal cancer, pap test glandular abnormality, fallopian tube carcinoma differential

Cara Buskmiller, Cline, B., & Xynos, F. (2019). Medical diligence uncovers fallopian tube cancer after abnormal Pap test. *BMJ case reports*, *12*(7), e229762. https://doi.org/10.1136/bcr-2019-229762